Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1988-12-16
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0040-5957
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
279-84
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2847346-Adult,
pubmed-meshheading:2847346-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:2847346-Etoposide,
pubmed-meshheading:2847346-Humans,
pubmed-meshheading:2847346-Male,
pubmed-meshheading:2847346-Middle Aged,
pubmed-meshheading:2847346-Neoplasms, Germ Cell and Embryonal,
pubmed-meshheading:2847346-Testicular Neoplasms
|
pubmed:articleTitle |
[Role of VP 16 in the treatment of non-seminomatous germ cell tumors of the testis].
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|